Cyduct Diagnostics Stock Market Value
| CYDX Stock | USD 0.20 0.00 0.00% |
| Symbol | Cyduct |
Cyduct Diagnostics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Cyduct Diagnostics' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Cyduct Diagnostics.
| 01/02/2025 |
| 12/28/2025 |
If you would invest 0.00 in Cyduct Diagnostics on January 2, 2025 and sell it all today you would earn a total of 0.00 from holding Cyduct Diagnostics or generate 0.0% return on investment in Cyduct Diagnostics over 360 days. Cyduct Diagnostics is related to or competes with Escalon Medical, Epigenomics, and Ligand Pharmaceuticals. CYduct Diagnostics, Inc., a healthcare instrument company, develops and markets technology, applications, medical device... More
Cyduct Diagnostics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Cyduct Diagnostics' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Cyduct Diagnostics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.0193 | |||
| Maximum Drawdown | 108.91 |
Cyduct Diagnostics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cyduct Diagnostics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Cyduct Diagnostics' standard deviation. In reality, there are many statistical measures that can use Cyduct Diagnostics historical prices to predict the future Cyduct Diagnostics' volatility.| Risk Adjusted Performance | 0.0288 | |||
| Jensen Alpha | 0.4398 | |||
| Total Risk Alpha | (0.81) | |||
| Treynor Ratio | (0.12) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Cyduct Diagnostics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Cyduct Diagnostics Backtested Returns
Cyduct Diagnostics appears to be out of control, given 3 months investment horizon. Cyduct Diagnostics secures Sharpe Ratio (or Efficiency) of 0.0278, which signifies that the company had a 0.0278 % return per unit of standard deviation over the last 3 months. We have found sixteen technical indicators for Cyduct Diagnostics, which you can use to evaluate the volatility of the firm. Please makes use of Cyduct Diagnostics' mean deviation of 2.42, and Risk Adjusted Performance of 0.0288 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Cyduct Diagnostics holds a performance score of 2. The firm shows a Beta (market volatility) of -2.25, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Cyduct Diagnostics are expected to decrease by larger amounts. On the other hand, during market turmoil, Cyduct Diagnostics is expected to outperform it. Please check Cyduct Diagnostics' market risk adjusted performance, treynor ratio, as well as the relationship between the Treynor Ratio and day typical price , to make a quick decision on whether Cyduct Diagnostics' price patterns will revert.
Auto-correlation | -0.29 |
Weak reverse predictability
Cyduct Diagnostics has weak reverse predictability. Overlapping area represents the amount of predictability between Cyduct Diagnostics time series from 2nd of January 2025 to 1st of July 2025 and 1st of July 2025 to 28th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Cyduct Diagnostics price movement. The serial correlation of -0.29 indicates that nearly 29.0% of current Cyduct Diagnostics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.29 | |
| Spearman Rank Test | -0.49 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Cyduct Diagnostics lagged returns against current returns
Autocorrelation, which is Cyduct Diagnostics pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Cyduct Diagnostics' pink sheet expected returns. We can calculate the autocorrelation of Cyduct Diagnostics returns to help us make a trade decision. For example, suppose you find that Cyduct Diagnostics has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Cyduct Diagnostics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Cyduct Diagnostics pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Cyduct Diagnostics pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Cyduct Diagnostics pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Cyduct Diagnostics Lagged Returns
When evaluating Cyduct Diagnostics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Cyduct Diagnostics pink sheet have on its future price. Cyduct Diagnostics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Cyduct Diagnostics autocorrelation shows the relationship between Cyduct Diagnostics pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Cyduct Diagnostics.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Cyduct Pink Sheet Analysis
When running Cyduct Diagnostics' price analysis, check to measure Cyduct Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cyduct Diagnostics is operating at the current time. Most of Cyduct Diagnostics' value examination focuses on studying past and present price action to predict the probability of Cyduct Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cyduct Diagnostics' price. Additionally, you may evaluate how the addition of Cyduct Diagnostics to your portfolios can decrease your overall portfolio volatility.